ArticleTherapeutic innovation & regulatory science2022

Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?

Kevin Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.